GENNIEFY
Market News
Latest financial news and analysis from global markets
LOW
Global centres in India slow hiring as AI reshapes work, ANSR CEO says
By Haripriya Suresh and Shivansh Tiwary BENGALURU, May 18 (Reuters) - Global capability centres in India are being measured while hiring as companies are wary about the impact of geopolitical
NVDA
Better Buy: Micron or Nvidia Stock
Nvidia and Micron are both benefiting from artificial intelligence (AI) spending.
TSLA
China’s Xpeng begins mass production of robotaxis in Guangzhou
Chinese electric vehicle maker Xpeng said on Monday it had begun mass production of its first robotaxi at its Guangzhou headquarters, targeting fully driverless operations by early 2027. The Tesla rival is accelerating its shift toward driverless vehicles and humanoid robotics as competition intensifies in the world’s largest auto market. The new robotaxi, built on Xpeng's GX platform, is China’s first "production-ready, pre-assembled robotaxi model developed entirely with in-house technologies," the company said.
GOOGL
Warren Buffett's Successor, Greg Abel, Just Sold 16 Stocks, but Piled Into an AI Titan That's Now a Top-5 Position for Berkshire Hathaway
We're witnessing the dawn of a new era at Berkshire Hathaway, with tech stocks firmly on the menu.
SBUX
Better Buy: Starbucks vs. Dutch Bros Stock
Starbucks stock is thriving right now, while Dutch Bros stock is struggling.
AMZN
Is Amazon Starting an Nvidia-Style Run?
Amazon stock has jumped more than 30% since late March.
NVDA
Is Amazon Starting an Nvidia-Style Run?
Amazon stock has jumped more than 30% since late March.
INTC
Is Amazon Starting an Nvidia-Style Run?
Amazon stock has jumped more than 30% since late March.
AMZN
Amazon faces class action over tariff cost claims
The period spans from when tariffs were imposed under the IEEPA to the US Supreme Court’s ruling that the law did not give President Trump authority to impose them.
REGN
Regeneron shares fall 12% on disappointing melanoma trial data
Investing.com -- Regeneron Pharmaceuticals shares dropped nearly 12% in premarket trading on Monday after the company reported its phase 3 trial for fianlimab in metastatic melanoma failed to meet its primary endpoint.
ORCL
Oracle’s Expanding Defense AI Role And What It Could Mean For Investors
Oracle (NYSE:ORCL) expanded AI-focused defense partnerships with the U.S. Department of Defense, including support for secure, classified AI workloads. The company secured a multi year contract with the U.S. Air Force valued at $88 million for cloud modernization through 2028. These agreements cover agentic AI systems for military decision support and classified cloud infrastructure across U.S. national security operations. Oracle enters this phase of defense work with NYSE:ORCL trading at...
INTC
Rocket Lab vs. SpaceX: Which Stock is the Better Aerospace Buy?
Investors could have astronomical opportunities with Rocket Lab and SpaceX.